TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Today

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:31 PM

Yesterday

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 12:45 PM

Fri May 20

Supernova article.

TMFBiologyFool published an . 10:04 PM

Tue May 17

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 11:31 AM

Mon May 16

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:34 PM

Thu May 12

NL

Article

TMFBiologyFool published an article 9:20 PM

Emergent BioSolutions Inc in Transition

The biodefense company prepares for higher revenue and lower costs.

Rule Breakers article.

TMFBiologyFool published an update. 8:46 PM

Rule Breakers article.

TMFBiologyFool published an update. 8:36 PM

NL

Article

TMFBiologyFool published an article 7:48 PM

bluebird bio Inc: Catnapping in Cambridge

A sleepy first-quarter update from the biotech.

NL

Article

TMFBiologyFool published an article 4:50 PM

Exelixis, Inc. Prepares for Blastoff

The biotech launches Cabometyx for kidney cancer.

Rule Breakers article.

TMFBiologyFool published an update. 4:07 PM

Wed May 11

NL

Article

TMFBiologyFool published an article 4:09 PM

Why Endo International plc Investigated a Lower Price

The U.S. Attorney’s Office requests information from the drugmaker's contracts with pharmacy benefit managers.

Rule Breakers article.

TMFBiologyFool published an update. 12:03 AM

Tue May 10

NL

Article

TMFBiologyFool published an article 8:07 PM

Genomic Health, Inc. Earnings: Waiting for (More) Reimbursement

Volume growth from the cancer-test maker was outstanding, and while there's work to go on reimbursement, revenue increased 19% year over year.

Rule Breakers article.

TMFBiologyFool published an update. 1:42 PM

NL

Article

TMFBiologyFool published an article 1:03 PM

Ionis Pharmaceuticals Inc Is Burning Partners' Cash (Thank Goodness There's Lots of It)

Even with a drug on the market, it's all about the pipeline for this biotech.

Mon May 9

NL

Article

TMFBiologyFool published an article 7:01 PM

Why Horizon Pharma PLC Earned a Higher Stock Price

The spec pharma meets its expectations.

NL

Article

TMFBiologyFool published an article 4:01 PM

Why Celldex Therapeutics, Inc. Popped Today

It's a biotech thing.

Rule Breakers article.

TMFBiologyFool published an update. 2:55 PM

NL

Article

TMFBiologyFool published an article 2:06 PM

Momenta Pharmaceuticals: Waiting for Fewer Injections

Sales of Glatopa trudge along, but the big opportunity is for the three-times-a-week version of the drug.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 88.43
Player Rank 8663 out of 74876
Score 641.35
Score Change Today -36.54
Accuracy 66.67%
Active Picks 73
Total Picks 215
Best Pick MNKD (+235.52)
Worst Pick INCY (-745.68)
Average Score per Pick 2.98
Charms Earned 9
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1203
Recs Received 1635
People who have rec'd these posts 551
Recs to Posts Ratio (last 30 days) N/A
Threads Started 130
Threads Started Percentage 10.81 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 54.11 %
Show TMFBiologyFool’s 10 Latest Posts